Current Opinion in Infectious Diseases was launched in 1988. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of infectious diseases is divided into 11 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Professor Roger Finch is Professor of Infectious Diseases at the University of Nottingham, UK and Consultant Physician to the City Hospital, Nottingham and is Chairman of the NeLCD Advisory Committee. He graduated from the University of Birmingham and has held Postgraduate appointments at the Universities of Bristol and London, and also in the United States.
Professor Finch has authored more than 290 papers covering the fields of antimicrobial chemotherapy, lower respiratory tract infections and the pathogenesis of staphylococcal disease. He is currently European Editor of Current Opinion in Infectious Diseases and was formerly Editor-in-Chief of the Journal of Antimicrobial Chemotherapy as well as serving on the editorial boards of several international Infection journals. He has published several books and is co-editor of the reference work Antibiotic and Chemotherapy (8th Edition).
Professor Finch was formerly Chairman of the Working Party on Clinical Evaluation of Antibacterial Drugs, member of the European Working Party on Clinical Trials of Anti-infective Agents and Co-Chairman of the Working Party on Self-medication of antibacterials without prescription. He was formerly President of the British Infection Society, Chairman of the Federation of Infection Societies and subsequently President of the European Society of Clinical Microbiology and Infectious Diseases. He serves on several committees of the Department of Health dealing with antibiotic resistance. He is advisor to the European Commission and the Committee on Proprietary Medicinal Products.
Dr Thomas F. Patterson received his Bachelor of Arts degree from Baylor University in Waco, Texas and his Medical Doctor from the University of Texas Medical School at Houston, Texas. He completed his internship and residency at Vanderbilt University Medical School, in Nashville, Tennessee and Yale-New Haven Hospital, and a fellowship in infectious diseases at Yale University School of Medicine, New Haven, Connecticut where he also served as an Assistant Professor of Medicine.
Dr Patterson currently is a Professor of Medicine in Infectious Diseases and Director of the Infectious Diseases Fellowship Training Program at the University of Texas Health Science Center in San Antonio, Texas. He is also an Attending Physician at the South Texas Veterans Healthcare System, Audie Murphy Division, San Antonio and Director of the San Antonio Center for Medical Mycology.
He has extensive experience in opportunistic fungal infections. His clinical and research interests focus on the diagnosis and treatment of fungal diseases particularly in immunocompromised hosts. He has been involved in developing new antifungal drugs and in clinical trials of new antifungal compounds.
Dr Patterson has published and lectured extensively on fungal infections. He is a member of the American Board of Internal Medicine Subspecialty on Infectious Diseases and is co-Editor-in-Chief of the popular mycology website www.doctorfungus.org. He is a Fellow of the American College of Physicians and Past-President of the Texas Infectious Disease Society.
Dr Martin Fisher BSc, MBBS, FRCP is Consultant Physician in HIV and Genitourinary Medicine at Brighton and Sussex University Hospitals and Honorary Senior lecturer at Sussex University, Brighton, UK. After graduating from Guys Hospital, London University, he trained in HIV and Genitourinary Medicine at the Chelsea and Westminster and St Mary's Hospitals in London before taking up his current post in 1995. In addition to his clinical interests in outpatient and inpatient management of HIV infection, he leads an active research team with numerous ongoing studies including novel antiretroviral therapies and strategies, primary HIV infection, HIV/STI interactions, adherence to anti-HIV therapies, and novel strategies to improve detection of HIV and STIs. He is an active member of the British Association for Sexual Health and HIV (BASHH), Secretary to the British HIV Association (BHIVA), and is the Convenor of the Diploma in HIV Medicine.
Dr Anton Pozniak studied medicine at the University of Bristol and qualified as MBChB in 1979. He trained in GUM and HIV at the Middlesex Hospital, London, UK. He worked as a Consultant Physician in Zimbabwe where he researched for his doctorate in TB/HIV and moved back to the UK in 1991. He ran the HIV research unit at King's College, London before moving to his current position as Consultant Physician/Senior Lecturer at the Chelsea and Westminster Hospital, London in 1998, and is now Director of HIV Services. He became a fellow of the Royal College of Physicians in 1996.
He is a life member of the British HIV Association where he has helped co-ordinate and write the British HIV Association (BHIVA) anti-viral HIV guidelines and is chair of the TB/HIV guidelines committee. He was an advisor on HIV and AIDS to the UK Government Health Select Committee. He is a member of the UK Governments Expert Advisory Group on AIDS on the executive of the European AIDS Clinical Society and on the Governing Council of the International AIDS Society.
© 2010 Lippincott Williams & Wilkins, Inc.